Format

Send to

Choose Destination
Sci Transl Med. 2015 Feb 11;7(274):274ra17. doi: 10.1126/scitranslmed.aaa1009.

Glutamine-based PET imaging facilitates enhanced metabolic evaluation of gliomas in vivo.

Author information

1
Department of Pathology, University of Michigan, Ann Arbor, MI 41809, USA. svenneti@med.umich.edu thompsonc@mskcc.org lewisj2@mskcc.org.
2
Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA.
3
Molecular Pharmacology and Chemistry Program, MSKCC, New York, NY 10065, USA.
4
Cancer Biology and Genetics Program, MSKCC, New York, NY 10065, USA.
5
Medical Physics, MSKCC, New York, NY 10065, USA.
6
Human Oncology and Pathogenesis Program, MSKCC, New York, NY 10065, USA.
7
Radiochemistry and Imaging Sciences Service, Department of Radiology, MSKCC, New York, NY 10065, USA.
8
Radiochemistry and Molecular Imaging Probe Core, MSKCC, New York, NY 10065, USA.
9
Departments of Radiology and Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA.
10
Cancer Biology and Genetics Program, MSKCC, New York, NY 10065, USA. Human Oncology and Pathogenesis Program, MSKCC, New York, NY 10065, USA.
11
Department of Neurology, MSKCC, New York, NY 10065, USA.
12
Donald B. and Catherine C. Marron Cancer Metabolism Center, MSKCC, New York, NY 10065, USA.
13
Medical Physics, MSKCC, New York, NY 10065, USA. Department of Neurosurgery, MSKCC, New York, NY 10065, USA.
14
Molecular Imaging and Therapy Service, Department of Radiology, Memorial Sloan Kettering Cancer Center (MSKCC), New York, NY 10065, USA. Molecular Pharmacology and Chemistry Program, MSKCC, New York, NY 10065, USA.
15
Director, Solid Tumor Translational Research, Division of Human Biology, Fred Hutchinson Cancer Research Center, and Alvord Brain Tumor Center, University of Washington, Seattle, WA 98109, USA.
16
Human Oncology and Pathogenesis Program, MSKCC, New York, NY 10065, USA. Department of Neurology, MSKCC, New York, NY 10065, USA.
17
Molecular Pharmacology and Chemistry Program, MSKCC, New York, NY 10065, USA. Radiochemistry and Imaging Sciences Service, Department of Radiology, MSKCC, New York, NY 10065, USA. Radiochemistry and Molecular Imaging Probe Core, MSKCC, New York, NY 10065, USA. svenneti@med.umich.edu thompsonc@mskcc.org lewisj2@mskcc.org.
18
Cancer Biology and Genetics Program, MSKCC, New York, NY 10065, USA. Human Oncology and Pathogenesis Program, MSKCC, New York, NY 10065, USA. svenneti@med.umich.edu thompsonc@mskcc.org lewisj2@mskcc.org.

Abstract

Glucose and glutamine are the two principal nutrients that cancer cells use to proliferate and survive. Many cancers show altered glucose metabolism, which constitutes the basis for in vivo positron emission tomography (PET) imaging with (18)F-fluorodeoxyglucose ((18)F-FDG). However, (18)F-FDG is ineffective in evaluating gliomas because of high background uptake in the brain. Glutamine metabolism is also altered in many cancers, and we demonstrate that PET imaging in vivo with the glutamine analog 4-(18)F-(2S,4R)-fluoroglutamine ((18)F-FGln) shows high uptake in gliomas but low background brain uptake, facilitating clear tumor delineation. Chemo/radiation therapy reduced (18)F-FGln tumor avidity, corresponding with decreased tumor burden. (18)F-FGln uptake was not observed in animals with a permeable blood-brain barrier or neuroinflammation. We translated these findings to human subjects, where (18)F-FGln showed high tumor/background ratios with minimal uptake in the surrounding brain in human glioma patients with progressive disease. These data suggest that (18)F-FGln is avidly taken up by gliomas, can be used to assess metabolic nutrient uptake in gliomas in vivo, and may serve as a valuable tool in the clinical management of gliomas.

PMID:
25673762
PMCID:
PMC4431550
DOI:
10.1126/scitranslmed.aaa1009
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for HighWire Icon for PubMed Central
Loading ...
Support Center